Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastoma

Glioblastoma (GBM) is the most aggressive brain tumor, with a median survival of ~15 months. Targeted approaches have not been successful in this tumor type due to the large extent of intratumor heterogeneity. Mosaic amplification of oncogenes suggests that multiple genetically distinct clones are p...

Descripción completa

Detalles Bibliográficos
Autores principales: Walentynowicz, Kacper A., Engelhardt, Dalit, Cristea, Simona, Yadav, Shreya, Onubogu, Ugoma, Salatino, Roberto, Maerken, Melanie, Vincentelli, Cristina, Jhaveri, Aashna, Geisberg, Jacob, McDonald, Thomas O., Michor, Franziska, Janiszewska, Michalina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114292/
https://www.ncbi.nlm.nih.gov/pubmed/36920905
http://dx.doi.org/10.1016/j.celrep.2023.112235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114292/
https://www.ncbi.nlm.nih.gov/pubmed/36920905
http://dx.doi.org/10.1016/j.celrep.2023.112235

Ejemplares similares